The Collaborative Research Center 1530 (SFB1530) is a network of internationally visible investigators with highly complementary technical expertise in innovative lymphoma models, cutting-edge genomics and proteomics platforms, comprehensively characterized, large cohorts of lymphoma patients, powerful bioinformatics and a successful clinical trial infrastructure.

The SFB1530 is specifically designed to create a cooperation platform of clinicians and scientists with excellent track-records either in lymphoma or in inflammation research. In doing so, the overarching goal of the Collaborative Research Center is to create and strengthen synergies towards the discovery of patho-mechanisms and the identification of innovative therapeutic strategies beyond the lymphoma cell-autonomous level. The close interactions with oncology centers of excellence in Cologne, Essen, Frankfurt, Berlin and Heidelberg and with major German lymphoma and leukemia study groups will allow for a rapid translation of major findings into clinical application.

In summary, the SFB1530 will undertake a holistic and interdisciplinary effort, which will create a comprehensive inventory of the major patho-mechanisms that define high-risk B cell malignancies in their specific microenvironment as a molecular framework for mechanism-based therapies.

SFB 1530 | CRC 1530

Org chart

Teams

Offices